Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CellSeedTSE:7776 +0.44%55 FCF Yield % is -11.56 as of Jul. 14, 2026. GuruFocus rates TSE:7776 with a GF Score™ of 55/100 and a GF Value™ of 円162.45 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 1,409 Biotechnology companies, CellSeed ranks worse than 54.29% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
As of today, CellSeed's Trailing 12-Month Free Cash Flow is 円-1,015.69 Mil, and Market Cap is 円8,785.47 Mil. Therefore, CellSeed's FCF Yield % for today is -11.56%.
The historical rank and industry rank for CellSeed's FCF Yield % or its related term are showing as below:
TSE:7776'
s FCF Yield % Range Over the Past 10 Years
Min: -11.61 Med: 0 Max: 0
Current: -11.56
TSE:7776's FCF Yield % is ranked worse than 54.29% of 1409
companies
in the Biotechnology industry
Industry Median: -9.65
vs TSE:7776: -11.56
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
CellSeed FCF Yield % Related Terms
CellSeed FCF Yield % Historical Data
* Premium members only.
The historical data trend for CellSeed's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7776 vs VRTX, REGN, ALNY: FCF Yield % Comparison
For the Biotechnology subindustry, CellSeed's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CellSeed FCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, CellSeed's FCF Yield % distribution charts can be found below:
* The bar in red indicates where CellSeed's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CellSeed (TSE:7776) has a FCF Yield % of -11.56 as of Jul. 14, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on CellSeed and its competitors. According to the industry distribution chart, CellSeed ranks #765 out of 1409 companies in the Biotechnology industry, placing it in the top 54.3%.
Is CellSeed's FCF Yield % too high?
CellSeed's current FCF Yield % is -11.56. Based on the distribution chart, CellSeed ranks #765 out of 1409 companies in the Biotechnology industry, which is below the industry midpoint. Overall, CellSeed has a GF Score™ of 55/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does CellSeed's FCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, CellSeed ranks #765 out of 1409 companies for FCF Yield %. This places CellSeed in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on CellSeed and its competitors. CellSeed's current FCF Yield % is -11.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CellSeed stock overvalued right now?
Based on GuruFocus' analysis, CellSeed (TSE:7776) is currently considered Significantly Overvalued. The stock's GF Value™ is 円162.45, compared to a current price of 円226.00 — trading 39.1% above its estimated fair value. The current FCF Yield % is -11.56. CellSeed's overall GF Score™ is 55/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For CellSeed (TSE:7776), the current FCF Yield % is -11.56 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CellSeed (TSE:7776) Overvalued in 2026?
Based on GuruFocus' analysis, CellSeed stock appears to be overvalued.
The current stock price of 円226.00 is trading 39.1% above its estimated GF Value™ of 円162.45.
GuruFocus considers CellSeed to be Significantly Overvalued.
Key valuation signals for TSE:7776:
FCF Yield %: -11.56
GF Value™: 円162.45 vs. price of 円226.00 (39.1% above fair value)
No single metric tells the full story. See the TSE:7776 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CellSeed Inc is a Japanese biotechnology company. The company is involved in the research, development, marketing, and sale of cell-sheet regenerative medicines, such as epithelial cell sheets for corneal and esophageal regeneration; regenerated cardiac patches to treat heart diseases; cell sheets for periodontal tissue regeneration; and regenerated cartilage sheets for the treatment of osteoarthritis.
55GF Score
Get the complete analysis for TSE:7776
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7776 has been successfully added to your 
